38583-85-6Relevant articles and documents
METHODS OF PREVENTING, REDUCING OR TREATING MACULAR DEGENERATION
-
Page/Page column 42, (2016/06/28)
The present invention is directed to selective adenosine A1 agonist compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat, reduce or prevent age-related macular degeneration.
METHOD OF REDUCING INTRAOCULAR PRESSURE IN HUMANS
-
Page/Page column 32; 33, (2010/11/17)
Provided herein are compounds of Formula I, compositions comprising an effective amount of a compound of Formula I, and methods for reducing intraocular pressure comprising administering an effective amount of compounds of Formula I to a subject in need t
Anti-dementia agents
-
, (2008/06/13)
An anti-dementia agent comprising as an active ingredient an adenosine derivative is disclosed. The anti-dementia agent is useful in the therapy of various types of dementia, especially senile dementia. Examples of the adenosine derivative include L-N6 -phenylisopropyl-adenosine, 2-chloroadenosine, N6 -cyclohexyladenosine, adenosine-5'-(N-cyclopropyl)carboxamide.